Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05246631Phase 4Completed
Phase 4, randomised, double-blind trial of haloperidol in postoperative nausea and vomiting (PONV) and pain (2 arms), sponsored by Universitas Indonesia. Primary endpoint: Postoperative Nausea and Vomiting at 24 hours. Started Jan 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05246631.